Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Kiss

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Molecular Biology|February 1, 2011
Optimization of the in-silico-designed kemp eliminase KE70 by computational design and directed evolutionOlga Khersonsky, Daniela Röthlisberger, Andrew M Wollacott, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2012
Iterative approach to computational enzyme designHeidi K Privett, Gert Kiss, Toni M Lee, et al.
Science (New York, N.Y.)|July 22, 2010
Computational design of an enzyme catalyst for a stereoselective bimolecular Diels-Alder reactionJustin B Siegel, Alexandre Zanghellini, Helena M Lovick, et al.
ACS Chemical Biology|January 22, 2013
Computational design of enone-binding proteins with catalytic activity for the Morita-Baylis-Hillman reactionSinisa Bjelic, Lucas G Nivón, Nihan Çelebi-Ölçüm, et al.
Nature Cell Biology|August 15, 2018
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancersRobert J Nichols, Franziska Haderk, Carlos Stahlhut, et al.
Journal of the American Chemical Society|August 9, 2012
Computational design of catalytic dyads and oxyanion holes for ester hydrolysisFlorian Richter, Rebecca Blomberg, Sagar D Khare, et al.
Nature Chemical Biology|October 7, 2021
Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growthBianca J Lee, Jacob A Boyer, G Leslie Burnett, et al.
Nature Chemical Biology|June 30, 2021
Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growthBianca J Lee, Jacob A Boyer, G Leslie Burnett, et al.
Nature Chemical Biology|June 25, 2021
Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growthBianca J Lee, Jacob A Boyer, G Leslie Burnett, et al.
Journal of Medicinal Chemistry|December 19, 2022
Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated TumorsG Leslie Burnett, Yu C Yang, James B Aggen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Molecular Biology|February 1, 2011
Optimization of the in-silico-designed kemp eliminase KE70 by computational design and directed evolutionOlga Khersonsky, Daniela Röthlisberger, Andrew M Wollacott, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2012
Iterative approach to computational enzyme designHeidi K Privett, Gert Kiss, Toni M Lee, et al.
Science (New York, N.Y.)|July 22, 2010
Computational design of an enzyme catalyst for a stereoselective bimolecular Diels-Alder reactionJustin B Siegel, Alexandre Zanghellini, Helena M Lovick, et al.
ACS Chemical Biology|January 22, 2013
Computational design of enone-binding proteins with catalytic activity for the Morita-Baylis-Hillman reactionSinisa Bjelic, Lucas G Nivón, Nihan Çelebi-Ölçüm, et al.
Nature Cell Biology|August 15, 2018
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancersRobert J Nichols, Franziska Haderk, Carlos Stahlhut, et al.
Journal of the American Chemical Society|August 9, 2012
Computational design of catalytic dyads and oxyanion holes for ester hydrolysisFlorian Richter, Rebecca Blomberg, Sagar D Khare, et al.
Nature Chemical Biology|October 7, 2021
Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growthBianca J Lee, Jacob A Boyer, G Leslie Burnett, et al.
Nature Chemical Biology|June 30, 2021
Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growthBianca J Lee, Jacob A Boyer, G Leslie Burnett, et al.
Nature Chemical Biology|June 25, 2021
Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growthBianca J Lee, Jacob A Boyer, G Leslie Burnett, et al.
Journal of Medicinal Chemistry|December 19, 2022
Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated TumorsG Leslie Burnett, Yu C Yang, James B Aggen, et al.
Pageof 2